4,924 Shares in SPDR S&P Biotech ETF $XBI Bought by Fort Sheridan Advisors LLC

Fort Sheridan Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 4,924 shares of the exchange traded fund’s stock, valued at approximately $493,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in XBI. Capital A Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth about $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $31,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $32,000. Davis Capital Management acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $40,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $127.12 on Tuesday. The company has a market capitalization of $8.49 billion, a P/E ratio of 11.47 and a beta of 0.93. The company’s 50 day moving average price is $125.25 and its two-hundred day moving average price is $114.38. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.